IWC
TEVA icon

Integrated Wealth Concepts’s Teva Pharmaceuticals TEVA Stock Holding History

Integrated Wealth Concepts’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$475K Sell
14,026
-7,442
-35% -$248K ﹤0.01% 1802
2026
Q1 		$647K Buy
+21,468
New +$691K 0.01% 1393

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Integrated Wealth Concepts's TEVA Position: Q2 2026 in Review

Integrated Wealth Concepts reduced its Teva Pharmaceuticals (TEVA) stake by 35% in Q2 2026, selling an estimated $248K and leaving 14,026 shares worth $475K. The position accounts for ﹤0.01% of the portfolio, ranked #1802.

Integrated Wealth Concepts first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $647K in Q1 2026. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Integrated Wealth Concepts held 14,026 shares of Teva Pharmaceuticals worth $475K as of Q2 2026.
  • Integrated Wealth Concepts sold 7,442 Teva Pharmaceuticals shares in Q2 2026, an estimated $248K.
  • Teva Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #1802 holding.
  • Integrated Wealth Concepts first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Integrated Wealth Concepts's Teva Pharmaceuticals position peaked at $647K in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.